Background: Recent scientific advances have provided a map of the human genome along with a better understanding of the processes that transform healthy cells into diseased cells. This has led to the emergence of a new class of drugs called targeted therapies.
Objective: To describe the classifications and basic pharmacology of targeted therapies.
Methods: A literature search was performed for peer reviewed journal articles using Medline (1996—2007), Embase (1996—2007) and Google. The search was performed using keywords such as angiogenesis inhibitors, cancer vaccines, gene therapy, monoclonal antibodies, small molecules, proteasome inhibitors, targeted therapy and tyrosine kinase inhibitors.
Conclusions: A review of the basic pharmacology is described in this article, including the following major categories of targeted therapies: • Small molecule drugs • Monoclonal antibodies • Apoptosis-inducing drugs • Angiogenesis Inhibitors • Cancer vaccines • Gene therapy J Oncol Pharm Practice (2007) 13: 199—205.
Viele CSKeys to unlock cancer: targeted therapy. Oncol Nurs Forum2005; 32: 935—40.
2.
Capriotti T.New oncology strategy: molecular targeting of cancer cells. Medsurg Nurs2004; 13: 191—5.
3.
Summerhayes M.What targeted therapy for cancer is and how it is achieved: a review. The Pharmaceutical Journal2006; 277: 518—25.
4.
PDQ® Cancer Information Summary. National Cancer Institute ; Bethesda MD. Targeted Cancer Therapies: Questions and Answers [Online]. 2004 [cited 2006 Sep 03; Available from: http://www.nci.nih.gov/cancertopics/factsheet/Therapy/targeted
5.
Spencer J.Targeted drugs for cancer treatment. Pharmacy Practice2006; 22: 1—7.
6.
Nelson M.Concepts in targeted cancer therapy. US Pharmacist2005; 30: 18—23.
7.
Segota E., Bukowski RMThe promise of targeted therapy: cancer drugs become more specific. Cleve Clin J Med2004; 71: 551—60.
8.
Ross JS, Schenkein DP, Pietrusko R., Rolfe M., Linette GP, Stec J. et al. Targeted therapies for cancer 2004. Am J Clin Pathol2004; 122: 598—609.
9.
Uro Today.Wyeth Submits NDA and MAA for Torisel for the Treatment of Advanced Renal Cell Carcinoma. 2006 October 09 [cited 2006 December 8; Available from: http://www.urotoday.com/38/browse_categories/renal_cancer/wyeth_submits_nda_and_maa_for_torisel_for_the_treatment_of_advanced_renal_cell_carcinoma.html
10.
Mauro MJDefining and managing imatinib resistance. Hematology Am Soc Hematol Educ Program Book 2006 — The American Society of Hematology2006; 219—25.
11.
Hayes D.Chemotherapy for metastatic breast cancer. In: UpToDateRose B, ed. Waltham, MA2007.
12.
Kuo CJOverview of angiogenesis inhibitors. In: UpToDateRose B, ed. Waltham, MA2007.
13.
Summerhayes M.Challenges in tumour targeting. The Pharmaceutical Journal2006; 277: 550—2.
14.
PDQ® Cancer Information Summary. National Cancer Institute. NCI Drug Dictionary. [cited 2006 December 14; Available from: http://www.cancer.gov/drugdictionary/
15.
B.C. Cancer Agency.Focus on Infusion Reactions from Monoclonal Antibodies. Systemic Therapy Update [serial online] 2004 May [cited 2006 Oct 12; 7: 4—5:[Available from: http://www.bccancer.bc.ca/HPI/systemictherapyarchive.htm
16.
U.S. Food and Drug Administration.FDA Approves New Combination Therapy for Lung Cancer. 2006 [cited 2006 Nov 9; Available from: http://www.fda.gov/bbs/topics/NEWS/2006/NEW01488.HTML
17.
UpToDate. Panitumumab: Drug information. In: UpToDateRose B, ed. Waltham, MA2007.
18.
PDQ® Cancer Information Summary. National Cancer Institute. Understanding Cancer Series: Angiogenesis . 2005 [cited 2007 Mar 19; Available from: http://www.cancer.gov/cancertopics/understandingcancer/angiogenesis
19.
PDQ® Cancer Information Summary. National Cancer Institute; Bethesda MD. Angiogenesis Inhibitors in Clinical Trials [Online]. 1999 [cited 2006 Sep 03; Available from: http://www.cancer.gov/clinicaltrials/developments/anti-angio-table/print?page=&keyword
20.
PDQ® Cancer Information Summary. National Cancer Institute; Bethesda MD. Cancer Vaccine Fact Sheet [Online]. 2003 [cited 2006 Sep 3; Available from: http://www.nci.nih.gov/cancertopics/factsheet/cancervaccine
21.
Waknine Y.International Approvals: Singulair and Gardasil/Silgard. Medscape Medical News2006 October 2 [cited 2006 December 13; Available from: http://www.medscape.com/viewarticle/545374
22.
Cross D., Burmester JKGene therapy for cancer treatment: past, present and future. Clin Med Res2006; 4: 218—27.
23.
Zlokovic BV , Apuzzo MLCellular and molecular neurosurgery: pathways from concept to reality—part I: target disorders and concept approaches to gene therapy of the central nervous system. Neurosurgery1997; 40: 789—803; discussion-4.
24.
Su ZZ, Madireddi MT, Lin JJ, Young CS, Kitada S., Reed JC et al. The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice. Proc Natl Acad Sci USA1998; 95: 14400—5.
25.
Zhao L., Samuels T., Winckler S., Korgaonkar C., Tompkins V., Horne MC et al. Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathways. MolCancer Res2003; 1: 195—206.
